Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Crystallization | 22 | 2025 | 83 | 3.860 |
Why?
|
| Zeolites | 6 | 2023 | 9 | 3.220 |
Why?
|
| Kidney Calculi | 5 | 2024 | 5 | 1.990 |
Why?
|
| Antimalarials | 6 | 2024 | 17 | 1.740 |
Why?
|
| Hemeproteins | 5 | 2024 | 15 | 1.670 |
Why?
|
| Microscopy, Atomic Force | 7 | 2025 | 37 | 1.390 |
Why?
|
| Calcium Oxalate | 4 | 2024 | 4 | 1.220 |
Why?
|
| Hemin | 7 | 2023 | 18 | 1.180 |
Why?
|
| Thermodynamics | 3 | 2025 | 43 | 1.050 |
Why?
|
| Plasmodium falciparum | 3 | 2024 | 9 | 0.920 |
Why?
|
| Nanoparticles | 2 | 2018 | 69 | 0.900 |
Why?
|
| Uric Acid | 1 | 2025 | 2 | 0.900 |
Why?
|
| Cholesterol | 1 | 2025 | 17 | 0.900 |
Why?
|
| Artemisinins | 2 | 2024 | 7 | 0.890 |
Why?
|
| Riboflavin | 1 | 2025 | 25 | 0.870 |
Why?
|
| Quinolines | 3 | 2023 | 21 | 0.860 |
Why?
|
| Solvents | 4 | 2025 | 23 | 0.840 |
Why?
|
| Coke | 1 | 2022 | 3 | 0.740 |
Why?
|
| Calcification, Physiologic | 1 | 2020 | 2 | 0.640 |
Why?
|
| Silicon Dioxide | 2 | 2022 | 19 | 0.610 |
Why?
|
| Calcium Phosphates | 1 | 2019 | 1 | 0.600 |
Why?
|
| Citric Acid | 1 | 2019 | 1 | 0.600 |
Why?
|
| Calcium Chelating Agents | 1 | 2019 | 1 | 0.600 |
Why?
|
| Renal Agents | 1 | 2017 | 2 | 0.530 |
Why?
|
| Macromolecular Substances | 1 | 2016 | 8 | 0.510 |
Why?
|
| Chloroquine | 4 | 2024 | 9 | 0.500 |
Why?
|
| Metals, Alkali | 1 | 2015 | 1 | 0.470 |
Why?
|
| Porosity | 3 | 2022 | 20 | 0.430 |
Why?
|
| Growth Inhibitors | 1 | 2013 | 1 | 0.420 |
Why?
|
| Kinetics | 4 | 2025 | 80 | 0.390 |
Why?
|
| Humans | 10 | 2024 | 4936 | 0.390 |
Why?
|
| Malaria | 2 | 2023 | 6 | 0.370 |
Why?
|
| Water | 3 | 2025 | 38 | 0.350 |
Why?
|
| Catalysis | 2 | 2022 | 61 | 0.320 |
Why?
|
| Polymers | 2 | 2022 | 41 | 0.300 |
Why?
|
| 2-Propanol | 1 | 2025 | 2 | 0.230 |
Why?
|
| Microfluidics | 1 | 2025 | 8 | 0.230 |
Why?
|
| Naphthyridines | 1 | 2024 | 2 | 0.220 |
Why?
|
| Drug Resistance | 1 | 2024 | 3 | 0.220 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2025 | 32 | 0.220 |
Why?
|
| Adsorption | 3 | 2018 | 44 | 0.200 |
Why?
|
| Disease Models, Animal | 1 | 2024 | 225 | 0.190 |
Why?
|
| Xylenes | 1 | 2022 | 3 | 0.190 |
Why?
|
| Methanol | 1 | 2022 | 5 | 0.190 |
Why?
|
| Toluene | 1 | 2022 | 5 | 0.190 |
Why?
|
| Surface Properties | 4 | 2017 | 77 | 0.180 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2021 | 7 | 0.170 |
Why?
|
| Fibroblasts | 1 | 2021 | 12 | 0.170 |
Why?
|
| Lung | 1 | 2021 | 35 | 0.170 |
Why?
|
| Heme | 2 | 2017 | 7 | 0.170 |
Why?
|
| Calcium Carbonate | 1 | 2020 | 1 | 0.160 |
Why?
|
| Ions | 1 | 2020 | 9 | 0.160 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2017 | 37 | 0.160 |
Why?
|
| Citrates | 1 | 2019 | 1 | 0.150 |
Why?
|
| Calcium Citrate | 1 | 2019 | 1 | 0.150 |
Why?
|
| Dietary Supplements | 1 | 2019 | 6 | 0.150 |
Why?
|
| Secondary Prevention | 1 | 2019 | 6 | 0.150 |
Why?
|
| X-Ray Diffraction | 2 | 2021 | 8 | 0.140 |
Why?
|
| Metal-Organic Frameworks | 1 | 2018 | 1 | 0.140 |
Why?
|
| Oxides | 1 | 2018 | 5 | 0.140 |
Why?
|
| Metals | 1 | 2018 | 17 | 0.140 |
Why?
|
| Amodiaquine | 1 | 2017 | 2 | 0.130 |
Why?
|
| Spectrophotometry | 1 | 2017 | 13 | 0.130 |
Why?
|
| Substrate Specificity | 1 | 2013 | 16 | 0.100 |
Why?
|
| Optical Imaging | 1 | 2013 | 17 | 0.100 |
Why?
|
| Octanols | 1 | 2013 | 3 | 0.100 |
Why?
|
| Flocculation | 1 | 2013 | 1 | 0.100 |
Why?
|
| Water Microbiology | 1 | 2013 | 1 | 0.100 |
Why?
|
| Filtration | 1 | 2013 | 3 | 0.100 |
Why?
|
| Microscopy, Electron | 1 | 2013 | 8 | 0.100 |
Why?
|
| Electrochemical Techniques | 1 | 2013 | 9 | 0.100 |
Why?
|
| Aluminum | 1 | 2013 | 4 | 0.100 |
Why?
|
| Levivirus | 1 | 2013 | 6 | 0.100 |
Why?
|
| Amines | 1 | 2013 | 6 | 0.100 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 44 | 0.100 |
Why?
|
| Models, Molecular | 1 | 2013 | 82 | 0.100 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2021 | 10 | 0.080 |
Why?
|
| Erythrocytes | 1 | 2024 | 10 | 0.060 |
Why?
|
| Mutation | 1 | 2024 | 132 | 0.050 |
Why?
|
| Animals | 2 | 2024 | 1711 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 1 | 2024 | 184 | 0.050 |
Why?
|
| Glutathione | 1 | 2021 | 7 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2021 | 34 | 0.040 |
Why?
|
| Mice | 1 | 2024 | 685 | 0.040 |
Why?
|
| Nanostructures | 1 | 2021 | 23 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 48 | 0.040 |
Why?
|
| Cell Survival | 1 | 2021 | 54 | 0.040 |
Why?
|
| Cell Line | 1 | 2021 | 84 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 73 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2021 | 115 | 0.040 |
Why?
|
| Monte Carlo Method | 1 | 2020 | 17 | 0.040 |
Why?
|
| Renal Elimination | 1 | 2019 | 1 | 0.040 |
Why?
|
| Diffusion | 1 | 2017 | 18 | 0.030 |
Why?
|
| Models, Chemical | 1 | 2017 | 34 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2017 | 36 | 0.030 |
Why?
|
| Binding Sites | 1 | 2017 | 66 | 0.030 |
Why?
|
| Vacuoles | 1 | 2015 | 2 | 0.030 |
Why?
|
| Solubility | 1 | 2013 | 10 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2013 | 36 | 0.030 |
Why?
|
| Swine | 1 | 2013 | 50 | 0.030 |
Why?
|
| Particle Size | 1 | 2013 | 41 | 0.030 |
Why?
|
| Temperature | 1 | 2013 | 60 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 24 | 0.020 |
Why?
|